|
AU2016204713A1
|
|
Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular Disorders
|
|
US2015140120A1
|
|
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
|
AU2014218429A1
|
|
Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
|
|
HK1213293A1
|
|
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
|
AU2013204622A1
|
|
Complement Binding Aptamers and Anti-C5 Agents Useful in the Treatment of Ocular Disorders
|
|
AU2012254935A1
|
|
Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
|
|
AU2007223796A1
|
|
Complement binding aptamers and anti-C5 agents useful in the treatment of ocular disorders
|
|
EP1737879A2
|
|
Aptamer-mediated intracellular delivery of therapeutic oligonucleotides
|
|
EP3385384A1
|
|
Aptamer therapeutics useful in the treatment of complement-related disorders
|
